ReferenceID 4570

Arctiin elevates osteogenic differentiation of MC3T3-E1 cells by modulating cyclin D1

Bioengineered

Osteoporosis is a systemic disorder of bone metabolism. This study aimed to investigate the impacts and possible mechanisms of Arctiin, a lignin isolated from Arctium lappa on MC3T3-E1 osteoblast differentiation. In this

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
4570
Evidence Id
21160
Core Evidence Id
21160
Source Reference Id
2411
Herb2 Reference Id
HBREF003208
Subject Paper Key
HBIN016620_35473505
Pubmed Id
35473505
Doi
10.1080/21655979.2022.2066047
Paper Title
Arctiin elevates osteogenic differentiation of MC3T3-E1 cells by modulating cyclin D1
Paper Abstract
Osteoporosis is a systemic disorder of bone metabolism. This study aimed to investigate the impacts and possible mechanisms of Arctiin, a lignin isolated from Arctium lappa on MC3T3-E1 osteoblast differentiation. In this study, after treatment with different concentrations of Arctiin, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting were used to estimate the expression of osteogenesis markers. Then, the activity of alkaline phosphatase (ALP) was detected by an ALP assay kit and calcium nodules staining was evaluated by alizarin red staining (ARS). Additionally, the regulatory effects of Arctiin on cyclin D1 (Ccnd1) was assessed by measurement of protein expression. Subsequently, the functions of Ccnd1 silencing on the osteogenic differentiation was examined in Arctiin-treated MC3T3-E1 cells. Results indicated that Arctiin dose-dependently upregulated the expression of runt-related transcription factor 2 (RUNX2), collagen type 1 (COL1A1), osteocalcin (OCN) and osteopontin (OPN). Elevated ALP activity and calcification degree was prominently observed in the Arctiin-treated groups. Moreover, Ccnd1 expression was notably enhanced after Arctiin intervention. Importantly, Ccnd1-knockdown abrogated the impacts of Arctiin on osteogenic differentiation of MC3T3-E1. To conclude, findings in this study suggested that Arctiin could regulate MC3T3-E1 osteoblast differentiation via up-regulating Ccnd1, supporting that Arctiin might be a therapeutic target for osteoporosis.
Journal
Bioengineered
Publish Year
2022
Experiment Subject
Experiment Type
Cell Experiment
Phenotype Related
Systemic Disorder Of Bone Metabolism; Osteoporosis
Paper Title Cn
Paper Title En
Arctiin elevates osteogenic differentiation of MC3T3-E1 cells by modulating cyclin D1
Bilingual Status
semi_complete